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Abstract
Background: There is variation in cardiac catheterization utilization across jurisdictions. Previous work from Alberta,
Canada, showed no evidence of a plateau in the yield of high-risk disease at cardiac catheterization rates as high
as 600 per 100,000 population suggesting that the optimal rate is higher. This work aims 1) To determine if a
previously demonstrated linear relationship between the yield of high-risk coronary disease and cardiac
catheterization rates persists with contemporary data and 2) to explore whether the linear relationship exists in
other jurisdictions.
Methods: Detailed clinical information on all patients undergoing cardiac catheterization in 3 Canadian provinces
was available through the Alberta Provincial Project for Outcomes Assessment in Coronary Heart (APPROACH)
disease and partner initiatives in British Columbia and Nova Scotia. Population rates of catheterization and high-risk
coronary disease detection for each health region in these three provinces, and age-adjusted rates produced using
direct standardization. A mixed effects regression analysis was performed to assess the relationship between
catheterization rate and high-risk coronary disease detection.
Results: In the contemporary Alberta data, we found a linear relationship between the population catheterization
rate and the high-risk yield. Although the yield was slightly less in time period 2 (2002-2006) than in time period 1
(1995-2001), there was no statistical evidence of a plateau. The linear relationship between catheterization rate and
high-risk yield was similarly demonstrated in British Columbia and Nova Scotia and appears to extend, without a
plateau in yield, to rates over 800 procedures per 100,000 population.
Conclusions: Our study demonstrates a consistent finding, over time and across jurisdictions, of linearly increasing
detection of high-risk CAD as population rates of cardiac catheterization increase. This internationally-relevant
finding can inform country-level planning of invasive cardiac care services.
Background
Cardiac catheterization is one of the most commonly
performed invasive diagnostic procedures, yet it is also a
procedure for which there is tremendous variation in
utilization across countries and across jurisdictions
within countries [1-5]. This variation exists in the con-
text of a relative void of knowledge around what the
optimal rate of cardiac catheterization should really be.
Developed countries with relatively low rates of cardiac
catheterization, such as the United Kingdom, may be
under-using the procedure, or alternatively, countries
with high population rates, such as the United States,
may be overusing the procedure [2,6].
A previous study from our group provided some
insight into where a theoretically ‘optimal’ rate of car-
diac catheterization may reside [7]. Using 1995 to 2002
cardiac catheterization data from multiple health regions
in Alberta, Canada, we reported that the yield of detec-
tion of high-risk coronary artery disease (CAD) (i.e. tri-
ple vessel disease, left main disease, and two vessel
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disease with proximal LAD involvement) appeared to
increase linearly with an increase in cardiac catheteriza-
tion rates within health regions [7]. Furthermore, there
was no evidence of a plateau in the yield of high-risk
disease at cardiac catheterization rates as high as 600
procedures per 100,000 population, suggesting that the
optimal catheterization rate to detect high-risk CAD
(with continuing returns of high-risk disease detection)
is higher than this level. The detection of high-risk dis-
ease is indeed one of the primary goals of cardiac cathe-
terization, as only patients with high risk disease have
been shown to have significant survival and quality of
life benefits associated with the use of revascularization,
particularly in high-risk disease sub-groups [8,9].
Given that catheterization rates have continued to
change over time and that significant cardiac catheteri-
zation rate variation persists across geographic areas, we
conducted this ecological study to further evaluate the
relationship between population rates of cardiac cathe-
terization and the yield of high-risk disease within differ-
ent health care regions. We compiled detailed cardiac
catheterization data to determine if the previously
demonstrated linear increase in yield of high-risk disease
seen in Alberta, Canada persists in more recent years as
catheterization rates have continued to rise in that pro-
vince. We also explored whether this relationship exists
in health care regions in two other Canadian provincial
jurisdictions, British Columbia and Nova Scotia.
Methods
Data Sources
We used the Alberta Provincial Project for Outcomes
Assessment in Coronary Heart (APPROACH) disease data-
base, which is a geographically defined, population-based
registry that captures all patients undergoing cardiac cathe-
terization in Alberta [10]. Corresponding cardiac catheteri-
zation data compiled through the partner cardiac registry
initiatives in British Columbia and Nova Scotia were simi-
larly obtained. The databases from each of the three Cana-
dian provinces contain detailed clinical information,
including demographic characteristics, co-morbidities and
therapeutic interventions. Information on coronary anat-
omy is stored using a cardiac reconstruction software pro-
gram (Heartview, Siemens Medical Systems). For the
purposes of this analysis, high-risk CAD is defined as
greater than 50% stenosis of the left-main coronary artery,
or similar stenotic disease involving 3-vessels, or 2-vessels
disease with involvement of the proximal left anterior des-
cending artery [7]. Ethics approval was obtained from each
respective academic institution ethics review board.
Study Regions and Time Periods
Alberta APPROACH data from Jan 1, 1995 to Dec 31,
2006 were used. Repeat procedures were excluded so
that individual patients would only be included once in
the analysis. The previous work reported data from
1995 to 2001 ("time period 1”) [7]. Due to a health
region boundary change in April, 2002, the data for
time period 1 (1995-2001) were re-analyzed for this
study using the Alberta lay-out of 9 health regions that
existed in 2006 to allow for seamless comparison in
yield of high-risk disease across the two time periods.
Only 2 of Alberta’s 9 health regions have cardiac cathe-
terization and revascularization facilities. These regions
provide invasive investigation and revascularization for
the entire province.
The Nova Scotia and British Columbia cardiac registry
initiatives provided corresponding data from 2002-2004
and 2000-2005, respectively. This represents the entire
dataset within each province for which Heartview and
catheterization data are available. The dataset for each
province includes all health authorities within each pro-
vince (i.e. complete geographically inclusive capture).
Nova Scotia has 9 District Health Authorities with car-
diac catheterization provided by 1 centre. British
Columbia has 5 Health Authorities, with cardiac cathe-
terization services offered in three urban centres.
Analysis
Analyses were completed for males and females separately
as the prevalence of coronary artery disease differs
between males and females and because the optimal
catheterization rate may differ between sexes. Patients
were categorized into health regions based on their resi-
dential postal code. All catheterization procedures were
included. For each region, the population rates of catheter-
ization and high-risk detection were calculated. Cardiac
catheterization rates were derived as the total number of
catheterization procedures divided by the total population
over the age of 20. Rates of high-risk CAD detected were
calculated as the number of patients with high-risk CAD
detected divided by the total population over the age of
20. Subsequently, using direct standardization, age-
adjusted rates were calculated. Data were categorized into
5 age categories; 20-34, 35-49, 50-64, 65-74 and over 75.
The number of cardiac catheterizations within each age
group was divided by the population in that category.
Rates of high-risk CAD were calculated in the same man-
ner. Weighting the age-specific rates with the 1996 Cana-
dian population, we thus obtained age-adjusted cardiac
catheterization and high-risk detection rates per 100,000
population. The 1996 census was used as the population
reference standard for age adjustment (by direct standardi-
zation) because this standard has been used in other nota-
ble procedure rate work [11], and comparability of rates
across studies was desired.
Subsequent analyses used these adjusted catheteriza-
tion rates and high-risk detection rates as data points.
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Initially, a scatter plot of the catheterization rate versus
the high-risk detection rate was constructed, with each
data point representing an individual year of data for a
particular region. For the Alberta data, we compared
more recent years of data with earlier years, in order to
determine whether relationships persisted over time. For
the other two provinces, the entire time period available
was reported without distinction between years.
Given that the unit of analysis for this study is the
health care region, rather than the individual patient, we
employed a least squares linear regression analysis to
assess the relationship between catheterization rate and
high-risk CAD detection. As the observations from each
region are not independent, we performed hierarchical
modeling using a mixed effects linear model with a ran-
dom effect for each region. In this analysis, we modeled
a shared fixed intercept (fixed at zero) and random
slopes. The results of this model were then used to plot
a single weighted line to reflect the linear relationship
between catheterization rate and high-risk CAD detec-
tion rate for all regions. The line of “best fit” with 95%
confidence lines was then overlaid on the scatter plot of
observed data. To explore if the relationship might be
different for patients with acute coronary syndrome
(ACS) or for those with stable coronary disease, we
repeated the above analysis, stratified by indication.
Lastly, we tested quadratic terms in the modeling pro-
cess for the data from each of the provinces studied. A
statistically significant quadratic term would indicate
evidence of a plateau in the yield of high-risk CAD asso-
ciated with increased catheterization rates. This was per-
formed separately for both time periods studied in the
Alberta data, and repeated for Nova Scotia and British
Columbia data.
Recognizing the complexity of the mixed effects mod-
eling described above, we performed a sensitivity analy-
sis using simpler ordinary least squares regression. This
latter analysis, while simpler, overlooks the non-inde-
pendence of some of the data points analyzed. The find-
ings of this sensitivity analysis are not presented here
but were similar to those of our hierarchical mixed
effects analysis.
Results
Alberta: Time Period 1 vs. Time Period 2
Table 1 presents the patient characteristics, intervention
rates and outcomes by regional tertile of utilization in
time period 1 and time period 2. The clinical character-
istics and utilization are generally stable across tertiles
and time periods. Table 2 shows the average population
of males and females over 20 years of age, along with
the crude and adjusted cardiac catheterization rates per
100,000 for each health region in Alberta in time peri-
ods 1 and 2. For males, the adjusted catheterization
rates ranged from 379.7 to 538.4 per 100,000 in time
period 1. In time period 2, the range is higher with
slightly less variation – i.e. population rates ranging
from 438.9 to 587.8 per 100,000. There is an increase
between time periods for both sexes, though females
continued to have consistently lower rates than males.
The scatter plot of catheterization rates vs. high-risk
rates and the results of the hierarchical modeling are
presented in Figure 1. Each individual point represents
one year of data for one health region. The results for 9
health regions analyzed in time period 1 (Panel A) con-
firm our previously reported findings for that period [7].
Time period 2 (Panel B), meanwhile, continues to show
a positive association between cases of high-risk CAD
detected and catheterization rates.
Describing the relationship quantitatively, for males in
time periods 1 and 2, for every 2.3 and 2.6 catheteriza-
tion procedures performed, respectively, an additional
high-risk CAD patient was detected. For females, the
detection rate is lower than males with an additional
high-risk patient detected in every 3.7 and 4.3 catheteri-
zation procedures performed in time periods 1 and 2,
respectively.
British Columbia and Nova Scotia
Table 3 presents the population, crude catheterization
rate and adjusted catheterization rate for British Colum-
bia and Nova Scotia. In general, the rates in both British
Columbia and Nova Scotia are higher than those seen in
Alberta, and as in Alberta, males have consistently
higher rates than females.
The linear relationship between catheterization rate
and high-risk yield is similarly demonstrated in both
provinces, with findings that closely resemble those
from Alberta (Figure 2). In British Columbia, every 2.4
catheterizations results in an additional high-risk case
for males whereas for females, every 3.8 catheterizations
results in an additional high-risk case. The detection
rate is slightly higher in Nova Scotia with an additional
high-risk case in every 2.1 catheterizations for males and
every 3.5 procedures for females.
Formal Testing for a Plateau in Yield of High-risk Disease
We formally assessed whether a plateau was evident in
the high-risk CAD detection rate as catheterization rates
increased. When using the Alberta data across both
time points, the coefficient of the quadratic term
entered into the regression model was not significant
(p-value = 0.64). Similarly, there was no evidence of a
significant quadratic term in either British Columbia (p-
value = 0.67) or Nova Scotia (p-value = 0.61). This find-
ing indicates that there is no statistical evidence of a
plateau in yield of high-risk disease, in a range of data
points extending to the highest catheterization rates
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seen in Nova Scotia of 850 procedures per 100,000
population.
Stratified Analysis by Indication for Catheterization
A similar linear relationship was found for both ACS
and non-ACS subgroups, and on formal testing for evi-
dence of a plateau, there was again no evidence of a sta-
tistically significant plateau in the relationship between
population rates of catheterization and yield of high risk
disease (test for quadratic term indicating plateau: p-
value = 0.43 for ACS and p-value = 0.167 for non-ACS)
(Figure 3). As observed in the overall analysis, the yield
of high-risk cases is lower in females than males for
both subgroups and both time periods.
Discussion
Our study demonstrates a consistent finding, over
time and across jurisdictions, of linearly increasing
detection of high-risk CAD as population rates of car-
diac catheterization increase. The results presented
here extend our previously reported findings [7],
by demonstrating the consistency of this finding
across provinces. In addition, the linear increase in
detection of high-risk disease appears to extend to







Characteristic (%) Time period 1 (N
= 5062)
Time period 2 (N
= 5994)
Time period 1 (N
= 16154)
Time period 2 (N
= 19508)
Time period 1 (N
= 23593)
Time period 2 (N
= 25422)
Mean Age (yrs.) 63.5 63.8 62.5 62.2 62.4 62.1
Male 69.4 69.6 71.3 70.3 68.5 70.1
Current Smoker 24.6 25.8 27.5 29.6 25.6 26.2
Cerebrovascular
disease
6.7 7.1 6.2 6.4 6.7 6.8
Congestive Heart
Failure
14.4 14.6 15.5 14.7 14.3 14.2
COPD 10.8 16.9 9.2 13.1 12.3 18.4
Diabetes 19.3 24.0 20.1 24.4 18.8 22.6
Dialysis 1.2 1.2 1.8 1.8 1.5 1.4
Hyperlipidemia 50.1 76.1 48.7 72.0 48.3 72.5
Hypertension 52.7 66.7 52.0 64.7 52.7 64.2
Lytic 10.7 9.4 7.1 5.0 7.9 3.0
Liver/GI 3.7 8.3 2.9 6.1 4.5 8.7
Malignancy 4.1 4.4 2.9 3.0 4.4 4.7
Peripheral Vascular
disease
8.1 7.4 6.3 7.6 8.6 7.4
Previous CABG 6.4 3.4 7.5 3.0 6.4 3.1
Previous PCI 8.2 4.4 6.1 3.4 9.7 4.5
Indication for
catheterization
Stable angina 26.4 27.6 25.5 30.5 29.7 30.0
Unstable angina 30.3 22.1 29.2 18.1 29.6 21.2
Myocardial infarct. 30.0 37.4 28.5 37.2 27.3 35.9
Other 13.3 12.9 16.8 14.2 13.4 12.9
Coronary Anatomy
Normal 20.3 25.9 21.2 26.7 25.9 29.7
Low risk 39.6 39.2 37.0 37.1 38.7 38.9
2-vessel involving
PLAD
4.2 3.4 5.2 3.4 3.8 2.8
3-vessel 27.9 23.3 27.8 23.7 24.7 21.6
Left Main 8.0 7.3 8.8 7.0 7.0 6.4
Revasc. within 1 year 54.0 54.5 51.8 55.0 50.3 51.0
CABG within 1 year 22.9 16.7 21.9 17.2 18.8 14.8
PCI within 1 year 32.5 38.7 31.5 39.1 33.0 37.4
Death within 1 year 4.9 3.9 5.7 4.6 4.6 4.2
Clement et al. BMC Health Services Research 2011, 11:323
http://www.biomedcentral.com/1472-6963/11/323
Page 4 of 10
catheterization rates beyond 800 procedures per
100,000 population.
These findings from Canada are of international
importance, because they provide insights for countries
with both lower and higher population rates of cardiac
catheterization. For countries with lower rates than
Canada’s, such as the United Kingdom (catheterization
rate for 2009: 380 per 100,000 [12]), Greece (catheteriza-
tion rate for 2007: 308 per 100,000 [13]), Spain
(catheterization rate for 2007: 282 per 100,000 [13]) and
Poland (catheterization rate for 2007: 337 per 100,000
[13]), our findings would suggest a high likelihood of
linearly increasing yield of high-risk disease if more pro-
cedures are performed, assuming that the burden of dis-
ease at a population-level is comparable to Canada’s, as
would be expected across many Westernized developed
countries [6]. Meanwhile, for countries with higher
catheterization rates, such as the United States
Table 2 Average population and average cardiac catheterization rates per 100 000 population over 20 years of age in
Alberta health regions
Time period 1 (1995-2001) Time period 2 (2002-2006)
















Male Female Male Female Male Female Male Female Male Female Male Female
1 49015 51643 462.1 191.4 442.3 183.8 51776 54544 475.6 207.4 438.9 196.5
2 31479 32202 432.6 185.3 430.7 183.6 35187 35360 514.0 247.6 515.4 246.2
3 352016 362599 466.6 214.9 538.4 257.0 410790 421669 477.0 204.6 540.4 242.6
4 89896 92029 506.0 218.8 502.7 225.5 99557 101748 547.0 251.3 536.2 255.5
5 36905 38073 438.4 183.4 379.7 162.4 38420 39702 602.9 249.2 512.6 221.7
6 317698 332086 463.3 181.7 494.6 200.3 351822 366323 505.6 217.8 526.8 235.2
7 56644 55758 480.2 190.8 483.6 215.2 59643 58513 544.5 243.5 534.0 270.6
8 41519 39831 384.9 141.8 432.4 177.9 45536 43794 532.0 257.2 587.8 310.6
9 18810 17442 309.0 102.4 474.3 188.0 23879 21521 361.6 150.7 527.3 293.0
* Based on the average of populations within time period
** Adjusted for age
 
¨  Males      ǔ = 0.430 X 
Ƒ  Females   ǔ = 0.272 X 
x  Males       ǔ = 0.381 X 
+  Females   ǔ = 0.235 X 
Panel B Alberta 2002-2006 Panel A Alberta 1995-2001 
Figure 1 Random slopes regression lines with 95% confidence bands for Alberta in time period 1 (Panel A - 1995-2001) and time
period 2 (Panel B - 2002-2006).
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(catheterization rate for 1995/96 for Medicare enrollees:
2270 per 100,000 [14]), Germany (catheterization rate
for 2007: 1229 per 100,000 [13])and Belgium (catheteri-
zation rate for 2007: 713 per 100,000 [13]), our findings
provide a methodological template for similar evalua-
tions of diagnostic yield [2]. Indeed, a similar statistical
analysis, with exploration of the presence or absence of
a plateau in yield of high-risk disease beyond population
rates of 1000 catheterization procedures per 100,000
population would be very informative for such a
country.
Implicit to our study is the assertion that the detection
of high-risk coronary artery disease is clinically impor-
tant. In the presence of coronary disease affecting the
Table 3 Average population and average cardiac catheterization rates per 100 000 population over 20 years of age in
British Columbia Health Authorities (2000-2005) and Nova Scotia District Health Authorities (2002-2004)
Health Authority Population aged > 20 yrs* Crude catheterization rate Adjusted catheterization rate**
British Columbia Male Female Male Female Male Female
1 272083 284886 589.9 279.1 465.5 243.0
2 279301 299197 804.8 358.4 644.5 301.3
3 424195 445112 510.4 214.1 507.7 222.0
4 546130 565514 686.5 313.8 673.4 315.2
5 112268 105168 465.1 219.4 484.9 259.8
Nova Scotia
1 23361 24312 779.2 446.2 617.8 352.7
2 23839 25080 729.8 386.8 615.2 334.7
3 30218 32002 650.3 350.1 545.9 305.3
4 26439 27537 887.2 468.4 790.1 424.6
5 12441 13209 888.2 575.5 697.7 443.1
6 17421 18840 617.1 291.9 524.9 249.8
7 17349 17959 582.1 314.7 476.8 267.0
8 47055 52323 1048.7 488.3 856.9 408.9
9 145278 156187 766.2 416.5 778.7 427.6
* Based on the average of populations within time period
** Adjusted for age
¨   Males       ǔ = 0.419 X 
Ƒ  Females   ǔ = 0.263 X 
¨   Males     ǔ = 0.477 X 
Ƒ  Females  ǔ = 0.283 X 
Panel A British Columbia (2000-2005) Panel B Nova Scotia (2002-2004) 
Figure 2 Random slopes regression lines with 95% confidence bands for British Columbia (2000-2005, Panel A) and Nova Scotia
(2002-2004, Panel B).
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left main coronary artery, or the three main coronary
vessels, previous randomized trials confirm survival ben-
efit from revascularization with either coronary artery
bypass grafting (CABG) or percutaneous coronary inter-
vention (PCI) [8,9,15]. Similarly, for patients with two
vessel disease and associated involvement of the
proximal left anterior descending artery, studies suggest
that there is benefit associated with undergoing revascu-
larization [16,17]. The corollary to these benefits of
revascularization is that undetected high-risk disease in
a population is undesirable, as it may result in prema-






¨   Males       ǔ = 0.464 X 
Ƒ  Females   ǔ = 0.247 X 
¨   Males       ǔ = 0.466 X 
Ƒ  Females   ǔ = 0.341 X 
x  Males       ǔ = 0.395 X 
+  Females   ǔ = 0.334 X 
x  Males       ǔ = 0.420 X 
+  Females   ǔ = 0.203 X 
Panel A ACS Time period 1 (1995-2001) Panel B ACS Time period 2 (2002-2006) 
Panel C Non-ACS Time period 1 (1995-2001) Panel D Non-ACS Time period 2 (2002-2006)
Figure 3 Random slopes regression lines for Alberta stratified by indication for catheterization (ACS/Non-ACS) in time period 1 and
time period 2.
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We present our results stratified by sex. Consistent
with other work, there is less catheterization utilization
in females [18-20]. In addition, the slope of the relation-
ship between catheterization rate and high-risk cases
detected differs between males and females indicating a
lower high-risk case yield in females. This is consistent
with the growing body of literature asserting that under-
lying disease and symptom presentation differs for
females [19,20].
Although an indepth investigation of why this varia-
tion in the population catheterization rate exists across
jurisdictions is outside the scope of this study, we do
examine the patient characteristics across tertiles of
catheterization utilization. The patient characteristics
are very consistent across tertiles suggesting that differ-
ences are unlikely to be due to variations in underlying
disease burden. Additionally, we examined the relation-
ship stratified by indication for catheterization. Similar
trends were observed as in the overall analysis indicating
that a plateau in high risk detection has not been
reached in the jurisdiction studied for either ACS or
non-ACS subgroups.
If regional cardiac programs were to adopt a strategy
of increasing cardiac catheterization rates, our study
does not provide information about how higher popula-
tion rates of cardiac catheterization ought to be
achieved. Given current evidence though, it is likely to
be more appropriate to increase the utilization of car-
diac catheterization after acute coronary syndromes
(ACS), since this approach is more consistent with exist-
ing clinical trials [15,21-23]. It is less certain whether it
would be appropriate to increase catheterization rates in
asymptomatic patients (or patients with stable angina)
who have high risk features noted on non-invasive car-
diac testing. Current work and guidelines, however,
recommend increased use of non-invasive testing strate-
gies and subsequent risk stratification which might lead
to higher catheterization yield [24,25]. Future work
should determine the optimal strategy for increasing
detection of high-risk patients taking into account con-
text specific factors such as the healthcare system, infra-
structure, patient and provider preferences.
Implicit to the assertion of benefit associated with
detection of high-risk disease is the assumption that
intervention is of proven benefit. Of some concern, the
clinical trials demonstrating benefit of CABG for
patients with high-risk disease were conducted over 20
years ago, in highly selected patients with only stable
angina (i.e. no ACS patients), and without the benefits
of contemporary medical therapy [26]. And indeed, the
results of the recent COURAGE trial underline the
uncertainty surrounding the overall benefit of revascu-
larization [27]. However, COURAGE did not include
ACS patients and relatively few of the included patients
had truly high-risk anatomy. Thus, this trial can not be
considered as proof that revascularization is not benefi-
cial. Rather, it does point to the persisting questions
around the overall value of invasive cardiac procedures.
The economic considerations surrounding an increase
in catheterization rates are also not explored by our
analysis. A national strategy of intentionally seeking, and
thus detecting, more individuals with high-risk disease
would have the potential to put considerable pressure
on existing personnel and infrastructure for revasculari-
zation procedures.
Our study has limitations. First, we examined popula-
tion rates of cardiac catheterization without also asses-
sing the appropriateness of procedures performed across
the regions studied. However, it is unlikely that this sig-
nificantly influences our study of the relationship
between catheterization rates and yield of high-risk dis-
ease, because previous work has shown that geographic
variability in catheterization rates is not significantly
explained by inappropriate procedure use [28]. A second
limitation is that we only age-adjusted and sex-stratified
our catheterization rates. Our analysis would have been
strengthened by further adjustment for the regional pre-
valence of CAD, but this information was not available
to us. We suspect that this latter limitation does not
systematically bias our results or undermine our main
study finding. Lastly, our work does not consider the
use of non-invasive testing. Its potential proliferation in
coming years may affect both rates of catheterization
and rates of high-risk yield. Future work will be needed
to continuously examine the relationship between yield
and catheterization rate as non-invasive imaging
becomes more prevalent.
Conclusions
We have demonstrated a consistent finding of linearly
increasing yield of high-risk CAD as population rates of
cardiac catheterization increase. This finding holds true
across three Canadian jurisdictions, and over time, and
its implications are relevant to the planning of cardiac
procedure utilization not only in Canada, but also in
countries with both lower and higher population rates
of cardiac catheterization.
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